Benzinga's Top #PreMarket Losers
June 18, 2014 at 08:12 AM EDT
Endocyte (NASDAQ: ECYT) dipped 19.95% to $6.18 in pre-market trading after the company reported that the company has regained global ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.